Ichikawa Y, Monden R, Kuzuhara H
RIKEN The Institute of Physical and Chemical Research, Saitama, Japan.
Carbohydr Res. 1988 Jan 15;172(1):37-64. doi: 10.1016/s0008-6215(00)90842-5.
Two key synthons for the title pentasaccharide derivative, methyl O-(methyl 2-O-benzoyl-3-O-benzyl-alpha-L-idopyranosyluronate)-(1----4)-6-O-acetyl- 2-azido - 3-O- benzyl-2-deoxy-beta-D-glucopyranoside and O-(methyl 2,3-di-O-benzyl-4-O- chloroacetyl-beta-D-glucopyranosyluronate)-(1----4)-3,6-di-O-acetyl-2-az ido-2- deoxy-alpha-D- glucopyranosyl bromide, were prepared from a common starting material, cellobiose. They were coupled to give a tetrasaccharide derivative that underwent O-dechloroacetylation to the corresponding glycosyl acceptor. Its condensation with the known 6-O-acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-alpha-D-glucopyranosyl bromide afforded a 77% yield of suitably protected pentasaccharide, methyl O-(6-O- acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-alpha-D-glucopyranosyl)-(1----4)- O- (methyl 2,3- di-O-benzyl-beta-D-glucopyranosyluronate)-(1----4)-O-(3,6-di-O-acetyl-2- azido-2 - deoxy-alpha-D-glucopyranosyl)-(1----4)-O-(methyl 2-O-benzoyl-3-O-benzyl-alpha-L- idopyranosyluronate)- (1----4)-6-O-acetyl-2-azido-3-O-benzyl-2-deoxy-beta-D-glucopyranoside. Sequential deprotection and sulfation gave the decasodium salt of methyl O-(2- deoxy-2-sulfamido-6-O-sulfo-alpha-D-glucopyranosyl)-(1----4)-O-(be ta-D- glucopyranosyl-uronic acid)-(1----4)-O-(2-deoxy-2-sulfamido-3,6-di-O-sulfo-alpha-D-gluco pyranosyl)- (1----4)-O-(2-O-sulfo-alpha-L-idopyranosyluronic acid)-(1----4)-2-deoxy-2- sulfamido-6-O- sulfo-beta-D-glucopyranoside (3). In a similar way, the trisaccharide derivative, the hexasodium salt of methyl O-(2-deoxy-2-sulfamido-6-O-sulfo-alpha-D- glucopyranosyl)- (1----4)-O-(beta-D-glucopyranosyluronic acid)-(1----4)-2-deoxy-2-sulfamido-3,6- di-O- sulfo-alpha-D-glucopyranoside (4) was synthesized from methyl O-(6-O-acetyl-2- azido- 3,4-di-O-benzyl-2-deoxy-alpha-D-glucopyranosyl)-(1----4)-O-(methyl 2,3-di-O- benzyl-beta- D-glucopyranosyluronate)-3,6-di-O-acetyl-2-azido-2-deoxy-alpha-D- glucopyranoside. The pentasaccharide 3 binds strongly to antithrombin III with an association constant almost equivalent to that of high-affinity heparin, but the trisaccharide 4 appears not to bind.
用于制备目标五糖衍生物的两个关键合成子,即O-(甲基2-O-苯甲酰基-3-O-苄基-α-L-艾杜吡喃糖醛酸甲酯)-(1→4)-6-O-乙酰基-2-叠氮基-3-O-苄基-2-脱氧-β-D-葡萄糖吡喃糖苷和O-(甲基2,3-二-O-苄基-4-O-氯乙酰基-β-D-葡萄糖吡喃糖醛酸甲酯)-(1→4)-3,6-二-O-乙酰基-2-叠氮基-2-脱氧-α-D-葡萄糖吡喃糖基溴化物,由常见起始原料纤维二糖制备而成。将它们偶联得到一种四糖衍生物,该衍生物经O-脱氯乙酰化反应生成相应的糖基受体。其与已知的6-O-乙酰基-2-叠氮基-3,4-二-O-苄基-2-脱氧-α-D-葡萄糖吡喃糖基溴化物缩合,得到产率为77%的适当保护的五糖,即O-(6-O-乙酰基-2-叠氮基-3,4-二-O-苄基-2-脱氧-α-D-葡萄糖吡喃糖基)-(1→4)-O-(甲基2,3-二-O-苄基-β-D-葡萄糖吡喃糖醛酸甲酯)-(1→4)-O-(3,6-二-O-乙酰基-2-叠氮基-2-脱氧-α-D-葡萄糖吡喃糖基)-(1→4)-O-(甲基2-O-苯甲酰基-3-O-苄基-α-L-艾杜吡喃糖醛酸甲酯)-(1→4)-6-O-乙酰基-2-叠氮基-3-O-苄基-2-脱氧-β-D-葡萄糖吡喃糖苷。通过依次脱保护和硫酸化反应得到甲基O-(2-脱氧-2-氨磺酰基-6-O-磺基-α-D-葡萄糖吡喃糖基)-(1→4)-O-(β-D-葡萄糖醛酸)-(1→4)-O-(2-脱氧-2-氨磺酰基-3,6-二-O-磺基-α-D-葡萄糖吡喃糖基)-(1→4)-O-(2-O-磺基-α-L-艾杜吡喃糖醛酸)-(1→4)-2-脱氧-2-氨磺酰基-6-O-磺基-β-D-葡萄糖吡喃糖苷的十钠盐(3)。以类似的方式,由O-(6-O-乙酰基-2-叠氮基-3,4-二-O-苄基-2-脱氧-α-D-葡萄糖吡喃糖基)-(1→4)-O-(甲基2,3-二-O-苄基-β-D-葡萄糖吡喃糖醛酸甲酯)-3,6-二-O-乙酰基-2-叠氮基-2-脱氧-α-D-葡萄糖吡喃糖苷合成了三糖衍生物,即甲基O-(2-脱氧-2-氨磺酰基-6-O-磺基-α-D-葡萄糖吡喃糖基)-(1→4)-O-(β-D-葡萄糖醛酸)-(1→4)-2-脱氧-2-氨磺酰基-3,6-二-O-磺基-α-D-葡萄糖吡喃糖苷的六钠盐(4)。五糖3与抗凝血酶III强烈结合,其缔合常数几乎与高亲和力肝素相当,但三糖4似乎不结合。